Showing results (241-250 of 289) with videos related to
Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984
Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancerM Rozencweig, W ten Bokkel Huinink, F Cavalli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive daysI Wolff, K Bench, J H Beijnen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
Childhood acute promyelocytic leukemia in NicaraguaA Malta Corea, C Pacheco Espinoza, A Cantù Rajnoldi, et al.Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetics of VP16-213 given by different administration methodsM D'Incalci, P Farina, C Sessa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?J Bernhard, B Thürlimann, S F Schmitz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88B Thürlimann, K Beretta, M Bacchi, et al.Cancer Chemotherapy and Pharmacology|September 29, 1999
Phase I clinical and pharmacological study of oral methoxymorpholinyl doxorubicin (PNU 152243)C Sessa, M Zucchetti, M Ghielmini, et al.Israel Journal of Medical Sciences|February 1, 1995
The best available adjuvant treatments are within the framework of clinical trials. The International Breast Cancer Study GroupA Goldhirsch, R D Gelber, M Castiglione, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markersF Bertolini, W Mingrone, A Alietti, et al.European Journal of Cancer & Clinical Oncology|February 1, 1983
Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-GroupR De Jager, P Siegenthaler, F Cavalli, et al.Pageof 29